Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

2.
3.

Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels.

Muros MA, Llamas-Elvira JM, Ramírez-Navarro A, Gómez MJ, Rodríguez-Fernández A, Muros T, López de la Torre M, Becerra A, Carreras JL.

Am J Surg. 2000 Jun;179(6):457-61.

PMID:
11004330
4.

Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer.

Oh JR, Byun BH, Hong SP, Chong A, Kim J, Yoo SW, Kang SR, Kim DY, Song HC, Bom HS, Min JJ.

Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1459-68. doi: 10.1007/s00259-011-1809-x. Epub 2011 Apr 20.

PMID:
21505897
5.

[F-18-fluordeoxyglucose positron emission tomography on patients with differentiated thyroid cancer who present elevated human serum thyroglobulin levels and negative I-131 whole body scan].

Ruiz Franco-Baux JV, Borrego Dorado I, Gómez Camarero P, Rodríguez Rodríguez JR, Vázquez Albertino RJ, Navarro González E, Astorga Jiménez R.

Rev Esp Med Nucl. 2005 Jan-Feb;24(1):5-13. Spanish.

6.

Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.

Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M.

Q J Nucl Med Mol Imaging. 2008 Mar;52(1):2-8.

8.
9.

Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.

Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL.

Ann Surg Oncol. 2008 Jan;15(1):286-92. Epub 2007 Sep 20.

PMID:
17882493
11.

Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.

Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY.

J Nucl Med. 1999 Jun;40(6):986-92.

12.

Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.

Kim SJ, Lee TH, Kim IJ, Kim YK.

Eur J Radiol. 2009 Apr;70(1):17-24. doi: 10.1016/j.ejrad.2007.12.004. Epub 2008 Jan 18.

PMID:
18207685
13.

Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer.

Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H.

Eur J Nucl Med. 1997 Nov;24(11):1342-8.

PMID:
9371865
14.

The role of F-18-fluorodeoxyglucose positron emission tomography in the postoperative evaluation of differentiated thyroid cancer.

Alzahrani AS, Abouzied ME, Salam SA, Mohamed G, Rifai A, Al Sugair A, Amin T.

Eur J Endocrinol. 2008 May;158(5):683-9. doi: 10.1530/EJE-07-0903. Erratum in: Eur J Endocrinol. 2008 Jun 1;158(6):941. Al-Zahrani, Ali S [corrected to Alzahrani, Ali S].

15.
16.

Extensive lymph node metastases found by (18)F-FDG-PET/CT in a patient with diffuse sclerosing variant of papillary thyroid carcinoma.

Xu YH, Song HJ, Qiu ZL, Luo QY.

Hell J Nucl Med. 2011 May-Aug;14(2):188-9. No abstract available.

PMID:
21761030
17.

Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis.

Dong MJ, Liu ZF, Zhao K, Ruan LX, Wang GL, Yang SY, Sun F, Luo XG.

Nucl Med Commun. 2009 Aug;30(8):639-50. doi: 10.1097/MNM.0b013e32832dcfa7.

PMID:
19512954
18.

Detection of intraluminal tracheal metastasis of thyroid papillary carcinoma by 18F-FDG PET/CT.

Ozkan E, Araz M, Soydal C, Kucuk NO, Ibis E.

Clin Nucl Med. 2012 Jun;37(6):e160-1. doi: 10.1097/RLU.0b013e318248515e.

PMID:
22614217
19.

Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET.

Freudenberg LS, Antoch G, Frilling A, Jentzen W, Rosenbaum SJ, Kühl H, Bockisch A, Görges R.

Eur J Nucl Med Mol Imaging. 2008 May;35(5):950-7. doi: 10.1007/s00259-007-0634-8. Epub 2008 Jan 12.

PMID:
18193222
20.

[Diagnostics and treatment of differentiated thyroid cancer using nuclear medicine].

Morsing A, Bogsrud TV.

Ugeskr Laeger. 2012 Jun 25;174(26):1813-6. Danish.

PMID:
22735115
Items per page

Supplemental Content

Write to the Help Desk